Study of aragvadha churna in cystitis

Open randomized control clinical trial of aragvadha churna in the management of mutrakruchchra with reference to acute cystitis - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/101677

Enrollment

Registered

2026-01-20

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient Showing maximum classical signs and symptoms such as Sadah Mutrapravrutti Saruj Mutrapravrutti Muhur muhur Mutrapravrutti Patients with symptoms burning micturation painful micturation frequency urgency suprapubic pain

Exclusion criteria

Exclusion criteria: Pregnant women and lactating Mother UTI assosciated with calculus which needs surgical intervention staghorncalculi Patient having malignancy diabetes BPH traumatic causes Chronic kidney disease renal transplant patient unexplained Hematuria Neurological diseases causing urinary retension presence of foreign bodies such as indwellingcatheters and other drainage devices Pus cells greater than 15hpf PH of urine greater than 5.5

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of aragvadha churna in the management of mutrakruchchra on the basis of PH and pus cells Timepoint: 7 days	—

Secondary

Measure	Time frame
To study the adverse effects of aragvadha churna To review literature of mutrakruchchra acute cystitis reduction in sign & symptoms Timepoint: 7 days	—

Countries

India

Contacts

Public ContactDr Manoj Patil

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Centre

dr.patilmanoj77@gmail.com9422613195

Outcome results